ReviewImmunological reviews2025
Thymic Interferons: A Little Goes a Long Way.
Review in Immunological reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Fibroblast-driven collagen expansion and altered thymic medullary niches in 22q11.2 deletion syndrome.Journal of human immunity · 2026Article
- Thymic Dendritic Cells Revisited.Immunological reviews · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Central tolerance is an essential process that protects the mammalian immune system from developing autoimmune reactions by forming a self-tolerant repertoire of T cells. The extent of central tolerance depends on the diversity of self-peptide-major histocompatibility complexes that thymocytes encounter on thymic antigen-presenting cells (APCs). Decades of research have demonstrated that medullary thymic epithelial cells (mTECs), a unique type of APC of stromal origin, possess an extraordinary capacity to produce and present thousands of self-peptides to developing thymocytes. This ability is facilitated by various unconventional mechanisms, including AIRE-regulated promiscuous gene expression, mimicry of peripheral cell types, and cooperative antigen transfer between different thymic APCs. Recently, several studies have reported that mTECs and other thymus-resident cells also produce tonic inflammatory signaling, which shapes the thymic microenvironment and expands the repertoire of presented inflammation-associated self-antigens (ISA). In this review, we focus on thymic interferons (IFNs), pro-inflammatory molecules produced as self-antigens by mTECs. Beyond their role as rare self-antigens critical for tolerance induction, IFNs influence the thymic microenvironment by promoting sterile inflammation, regulating the maturation of thymic APCs, and shaping T cell selection. We will discuss the production and regulation of thymic IFNs and their role in APC maturation and T cell selection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.